Clinical Evaluation Requirements of Medical Device Software and Software As a Medical Device Including AI/ML-based Devices (ONLINE EVENT: Apr 28, 2026)

Key market opportunities lie in developing medical software and healthcare apps with a strong focus on safety, quality, and effectiveness. Leveraging AI/ML technologies, understanding clinical evaluation requirements, and navigating EU MDR and FDA regulations can give manufacturers a competitive edge.


Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Clinical Evaluation of Medical Device Software and Software as a Medical Device (Apr 28, 2026)" training has been added to ResearchAndMarkets.com's offering.

This course will provide a clear understanding of the the clinical evaluation requirements and their practical application for software products, including AI/ML-based devices.

Whether developing new medical software for more precise diagnosis and targeted treatment or a healthcare app for individuals concerned about their health, manufacturers are tasked to appreciably prove to authorities the safety, quality, and effectiveness of their products. The evaluation of clinical safety and performance, as well as the overall benefit-risk profile of the product, through a critical assessment of relevant data, is one of the key requirements for the manufacturers of a medical device software and a focus area for regulators.

It will also provide advice on how to determine the type and amount of data needed to sufficiently support the intended medical purpose and (individual) clinical claims, with many practical examples and analysis of differences between EU MDR and FDA approach.

Who Should Attend:

  • Clinical and regulatory affairs professionals
  • Medical software R&D engineers and scientists
  • Product and programme managers
  • Quality assurance professionals

Key Topics Covered:

  • Introduction to clinical evaluation
  • How to define a scope and a level of clinical evidence for medical device software
  • Case studies - clinical evaluation of medical device software
  • Clinical trials and validation studies
  • Clinical evaluation post-market

CPD Hours: 6

Speakers

Zuzanna Kwade

Zuzanna Kwade is Software Clinical Evaluation Lead at Dedalus Healthcare. Zuzanna holds a PhD in Biochemistry and has 15 years of experience in clinical and medical research. She is the co-author of several white papers on regulatory aspects of clinical research and clinical evaluation.

Since 2016, she has been actively involved in Clinical Evaluations according to MEDDEV 2.7.1 (Rev.4) for multiple devices, including high risk hardware devices and medical software. She also represented COCIR in the European Union Task Force on clinical evaluation of software and co-authored MDCG2020-1 guidance on clinical evaluation of MDSW.

For more information about this training visit https://www.researchandmarkets.com/r/bfrl2g

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data

GlobeNewswire

Recommended Reading